TipRanks
Atrys Health SA (DE:A2T)
FRANKFURT:A2T

Compare Atrys Health SA (A2T) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Atrys Health SA
€2.85
€199.06M
-2.01
-7.03%
―
Oryzon Genomics SA
€2.86
€225.71M
-87.56
-13.54%
2 Buy
0 Hold
0 Sell
Moderate Buy
Pharma Mar SA
€82.80
€1.26B
21.88
-23.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
1nKemia IUCT Group SA
€0.31
€8.21M
―
0.00%
―
PRIM, S.A.
€13.20
€211.86M
16.58
-6.67%
―
Labiana Health SA
€6.20
€50.09M
16.78
41.18%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:A2T
Atrys Health SA
2.45
-0.38
-13.30%
ES:ORY
Oryzon Genomics SA
2.73
-0.61
-18.33%
ES:PHM
Pharma Mar SA
71.40
-17.96
-20.10%
ES:IKM
1nKemia IUCT Group SA
0.31
0.00
0.00%
ES:PRM
PRIM, S.A.
12.60
-0.61
-4.65%
ES:LAB
Labiana Health SA
5.90
1.68
39.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts